Face filler expected to soar with cases of gaunt ‘Ozempic face’ — and one company is cashing in
NY Post
A saggy, sunken face is a hallmark of Ozempic use, but one pharmaceutical company wants to fix that.
Dubbed “Ozempic face,” a term coined by celebrity dermatologist Dr. Paul Jarrod Frank, the gaunt appearance is a growing adverse effect of the weight loss drug due to a loss of facial volume, which Flemming Ornskov, the CEO of the Swiss skincare giant Galderma, wants to solve with filler.
“I think that will be another growth wave in that space, which I will make sure to capture,” Ornskov told Bloomberg, referring to the anticipated surge of facial filler requests as a result of Ozempic use.
Galderma is now studying the efficacy of fillers like Sculptra and Restylane “for cheek augmentation and contour deficiencies in GLP-1 patients,” a spokesperson told Business Insider.
The filler then can restore some of the plumpness in the face, which becomes deflated after losing excessive weight quickly.
The Post has reached out to Galderma representatives for further comment.
The Food and Drug Administration will decide on a ban of certain food dyes in the coming weeks after receiving a petition to review the safety of Red 3, NBC News reports.
There’s something extra special about New York City during the holidays.
That little red Elf on the Shelf can be a pain in the neck for parents during the festive season.
Saks Fifth Avenue may have gone dark on its traditional lavish holiday light show this year, but these Manhattan hotels have gone into sparkle overdrive to brighten the festive season.
Saks Fifth Avenue may have gone dark on its traditional lavish holiday light show this year, but these Manhattan hotels have gone into sparkle overdrive to brighten the festive season.
’Tis the season of giving — and spending.
Most folks return home from a Disney vacation with a pair of Mickey Mouse ears.